These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 20565229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Anticholinergics and their cardiovascular effects--between fear and reality].
    Mihălţan F, Ulmeanu R.
    Pneumologia; 2010; 59(2):107-8. PubMed ID: 20695368
    [No Abstract] [Full Text] [Related]

  • 4. [Tiotropium bromide in the treatment of chronic obstructive lung disease].
    Shmelev EI.
    Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anticholinergic treatment in airways diseases.
    Flynn RA, Glynn DA, Kennedy MP.
    Adv Ther; 2009 Oct; 26(10):908-19. PubMed ID: 19967500
    [Abstract] [Full Text] [Related]

  • 8. Tiotropium versus salmeterol in COPD.
    Oba Y.
    N Engl J Med; 2011 Jun 30; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract] [Full Text] [Related]

  • 9. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
    Singh S, Furberg CD.
    Arch Intern Med; 2011 May 23; 171(10):920-2. PubMed ID: 21606097
    [No Abstract] [Full Text] [Related]

  • 10. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK.
    Issues Emerg Health Technol; 2002 Jul 23; (35):1-4. PubMed ID: 12195603
    [Abstract] [Full Text] [Related]

  • 11. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG.
    BJU Int; 2011 Apr 23; 107(8):1265-72. PubMed ID: 20880196
    [Abstract] [Full Text] [Related]

  • 12. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL.
    An Med Interna; 2002 Dec 23; 19(12):640-3. PubMed ID: 12593035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anticholinergic agents in asthma and COPD.
    Gross NJ.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):36-9. PubMed ID: 16488410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun 08; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The safety of tiotropium--the FDA's conclusions.
    Michele TM, Pinheiro S, Iyasu S.
    N Engl J Med; 2010 Sep 16; 363(12):1097-9. PubMed ID: 20843240
    [No Abstract] [Full Text] [Related]

  • 19. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S, Loke YK, Enright P, Furberg CD.
    Thorax; 2013 Jan 16; 68(1):114-6. PubMed ID: 22764216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.